Viewing StudyNCT01670500



Ignite Creation Date: 2024-05-06 @ 12:50 AM
Last Modification Date: 2024-10-26 @ 10:55 AM
Study NCT ID: NCT01670500
Status: COMPLETED
Last Update Posted: 2022-05-25
First Post: 2012-08-16

Brief Title: Cisplatin vs DoxorubicinCyclophosphamide in BrCa
Sponsor: Beth Israel Deaconess Medical Center
Organization: Dana-Farber Cancer Institute

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords:
Name View
BRCA2 mutation View
germline mutation View
BRCA1 mutation View